CellTrax

  • CellTrax

Fact: 1 in 3 people will suffer from cancer. Fact: without metastasis the cancer patient survival rate increases by 500%.Research Institutes and Pharmaceutical companies are focusing on the study and prevention of cancerous cell progression. CellTrax offers an essential tool for these companies to minimize R&D costs, time, and human resources. Our integrated assortment of hardware and software advances provides a platform to efficiently track cell migration. Our solutions extend beyond cancer research to address a wide range of pharmaceutical R&D needs.

  • Michalis Makrominas
  • Timothi Constantinou
  • Alexandros Charalambides
  • George Tzirkotis